# Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma Participants

> **NCT02536664** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 505 (actual)

## Conditions studied

- Follicular Lymphoma

## Interventions

- **DRUG:** Rituximab

## Key facts

- **NCT ID:** NCT02536664
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 505 (ACTUAL)
- **Last updated:** 2023-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02536664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02536664, "Non-Interventional Study to Examine Rituximab Treatment in Follicular Lymphoma Participants". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02536664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*